News

Divestment of selected generic product portfolio

April 4, 2018

In keeping with the Company’s recently announced Generics Strategy, whereby IDT is to advance a selected generics portfolio and to build on the Company’s existing Commercial API and Contract Manufacturing businesses, IDT Australia has divested a majority of the Company’s generic ANDA product portfolio to ANI Pharmaceuticals Inc. Under the terms of the divestment, IDT…

Read More »